Veterinary Vaccines. Global Market Research Report. 12 Major 360 in Corporate Directory Exhibits: 116 Price: US$ Published: January 2017

Transcription

1 Global Research Report Veterinary Vaccines Published: January 2017 Pages: 342 Companies: 12 Major 360 in Corporate Directory Exhibits: 116 Price: US$ 2295 R I TECHNOLOGIES

2 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT 1. SCOPE AND METHODOLOGY 1.1 Scope of the Study 1.2 Research Methodology 1.3 Units and Currency 2. REPORT SYNOPSIS 2.1 Introduction Immunology Immunity Importance of A/A Vaccine 2.2 Segmentation of Veterinary Vaccines Exhibit 1. Segmentation of Global Veterinary Vaccines by Type and by Species 2.3 Veterinary Vaccines - Global Analysis Exhibit 2. Veterinary Vaccines - Global Historic, Current, and Forecast ( ) in US$ Billion Exhibit 3. List of Major Global Veterinary Vaccines Companies 3. MARKET DYNAMICS 3.1 Overview Trends Research and Selective Breeding T ABLE OF C ONTENTS Guidelines for Small-Animal Vaccines Plant-Based Vaccines DNA Vaccines Vaccines with Individual Antigens are Purer Drawbacks in the Development of Veterinary Vaccines 3.2 Global Veterinary Vaccines Analysis Vaccine Exhibit 4. Veterinary Vaccines - Global Historic, Current, and Forecast ( ) Veterinary Medicine - History by Geographic Region for Europe, North Vaccines America, Asia-Pacific, Latin America, Middle East and Rest of World in US$ Vaccination-Brief History Exhibit 5. Veterinary Vaccines - Global Preliminary Remarks on the Use of Vaccines Shares (2012, 2018 & 2022) by Geographic in Animals Region for Europe, North America, Asia-Pacific, Veterinarian-Role Latin America, Middle East and Rest of World Factors Determining Usage of Vaccines 3.3 European Veterinary Vaccines Selection of Vaccines Analysis Exhibit 6. Veterinary Vaccines - European Historic, Current, and Forecast ( ) by Country for France, Germany, UK, the Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 7. Veterinary Vaccines European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe 3.3 (I) French Veterinary Vaccines 3.3 (II) German Veterinary Vaccines 3.3 (III) UK Veterinary Vaccines 3.3 (IV) Dutch Veterinary Vaccines 3.3 (V) Swiss Veterinary Vaccines 3.3 (VI) Russian Veterinary Vaccines Competitor Overview Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies i

3 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT 3.4 North American Veterinary Vaccines Analysis Exhibit 8. Veterinary Vaccines - North American Historic, Current, and Forecast ( ) for United States, and Canada in US$ Exhibit 9. Veterinary Vaccines North American Shares (2012, 2018 & 2022) for United States, and Canada 3.4 (I) United States Veterinary Vaccines 3.4 (II) Canadian Veterinary Vaccines Competitor Overview 3.5 Asia-Pacific Veterinary Vaccines Analysis Exhibit 11. Veterinary Vaccines Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific 3.5 (I) Japanese Veterinary Vaccines 3.5 (II) Australian Veterinary Vaccines 3.5 (III) Chinese Veterinary Vaccines Trends in China China Pioneers a Live Vaccine to Control Bird Flu 3.5 (IV) Indian Veterinary Vaccines Trends in India 3.5 (VI) Taiwanese Veterinary Vaccines 3.5 (VII) South Korean Veterinary Vaccines Competitor Overview T ABLE OF C ONTENTS 3.6 Latin American Veterinary Vaccines Analysis Exhibit 12. Veterinary Vaccines - Latin American Historic, Current, and Forecast ( ) in by Country for Brazil, Mexico and Rest of Latin America US$ Exhibit 13. Veterinary Vaccines Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America 3.6 (I) Brazilian Veterinary Vaccines 3.6 (II) Mexican Veterinary Vaccines Competitor Overview 3.7 Middle East Veterinary Vaccines Exhibit 14. Veterinary Vaccines - Middle East Exhibit 10. Veterinary Vaccines - Asia-Pacific Historic, Current, and Forecast (2010 Historic, Current, and Forecast ( ) by Country Israel and Rest of Middle ) in by Country for Japan, RI Australia, Technologies, East in US$ China, India, Taiwan, South Korea and Rest of Asia-Pacific US$ Overview Exhibit 15. Veterinary Vaccines Middle East Shares (2012, 2018 & 2022) by Country for Israel and Rest of Middle East 3.7 (I) Israeli Veterinary Vaccines 3.8 Rest of World Veterinary Vaccines Analysis Exhibit 16. Veterinary Vaccines - Rest of World Historic, Current, and Forecast ( ) by Country for South Africa and Other Countries in US$ Exhibit 17. Veterinary Vaccines Rest of World Shares (2012, 2018 & 2022) ) by Country for South Africa and Other Countries 3.8 (I) South African Veterinary Vaccines Competitor Overview 3.9 Analysis by Species Exhibit 18. Veterinary Vaccines by Species - Global Historic, Current, and Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies ii

4 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Forecast ( ) in for Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other US$ Exhibit 19. Veterinary Vaccines by Species- Global Shares (2012, 2018 & 2022) for Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine, and Other Bovine Vaccines Global Bovine Vaccines Exhibit 20. Bovine Vaccines - Global Historic, Current, and Forecast ( ) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World in US$ Exhibit 21. Bovine Vaccines - Global Shares (2012, 2018 & 2022) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World European Bovine Vaccines Exhibit 22. Bovine Vaccines - European Historic, Current, and Forecast ( ) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 23. Bovine Vaccines - European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe North American Bovine Vaccines Exhibit 24. Bovine Vaccines - North American Historic, Current, and Forecast ( ) by Country for United States and Canada in US$ T ABLE OF C ONTENTS Exhibit 25. Bovine Vaccines - North American Shares (2012, 2018 & 2022) by Country for United States and Canada Asia-Pacific Bovine Vaccines Exhibit 26. Bovine Vaccines - Asia-Pacific Historic, Current, and Forecast ( ) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific in US$ Exhibit 27. Bovine Vaccines - Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia- Pacific Latin American Bovine Vaccines Exhibit 28. Bovine Vaccines - Latin American Historic, Current, and Forecast ( ) by Country for Brazil, Mexico and Rest of Latin America in US$ Exhibit 29. Bovine Vaccines - Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America Middle East Bovine Vaccines Exhibit 30. Bovine Vaccines - Middle East Historic, Current, and Forecast ( ) by country for Israel and Rest of Middle East in US$ Exhibit 31. Bovine Vaccines - Middle East Shares (2012, 2018 & 2022) by Country for Israel and Rest of Middle East Rest of World Bovine Vaccines Exhibit 32. Bovine Vaccines - Rest of World Historic, Current, and Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies iii

5 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Forecast ( ) by Country for South Africa and Other Countries in US$ Exhibit 33. Bovine Vaccines Rest of World Shares (2012, 2018 & 2022) by Country for South Africa and Other Countries Porcine Vaccines Global Porcine Vaccines Exhibit 34. porcine vaccines - Global Historic, Current, and Forecast ( ) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World in US$ European Porcine Vaccines Exhibit 36. Porcine Vaccines - European Historic, Current, and Forecast ( ) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 37. Porcine Vaccines - European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe North American Porcine Vaccines Exhibit 38. Porcine Vaccines - North American Historic, Current, and Forecast ( ) by Country for United States and Canada in US$ T ABLE OF C ONTENTS Exhibit 39. Porcine Vaccines - North American Shares (2012, 2018 & 2022) by Country for United States and Canada Asia-Pacific Porcine Vaccines Exhibit 40. Porcine Vaccines - Asia-Pacific Historic, Current, and Forecast ( ) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific in US$ Exhibit 41. Porcine Vaccines - Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia- Pacific Exhibit 35. Porcine Vaccines - Global Shares (2012, 2018 & 2022) by Latin American Porcine Geographic Region for Europe, North Vaccines America, Asia-Pacific, Latin America, Middle East and Rest of World Exhibit 42. Porcine Vaccines - Latin American Historic, Current, and Forecast ( ) by Country for Brazil, Mexico and Rest of Latin America in US$ Exhibit 43. Porcine Vaccines - Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America Middle East Porcine Vaccines Exhibit 44. Porcine Vaccines - Middle East Historic, Current, and Forecast ( ) by Country for Israel and Rest of Middle East in US$ Exhibit 45. Porcine Vaccines - Middle East Shares (2012, 2018 & 2022) by Country for Israel and Rest of Middle East Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies iv

6 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Rest of World Porcine Vaccines Exhibit 46. Porcine Vaccines - Rest of World Historic, Current, and Forecast ( ) by Country for South Africa and Other Countries in US$ Exhibit 47. Porcine Vaccines Rest of World Shares (2012, 2018 & 2022) by Country for South Africa and Other Countries Poultry Vaccines Global Poultry Vaccines Exhibit 48. Poultry Vaccines - Global Historic, Current, and Forecast ( ) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World in US$ Exhibit 49. Poultry Vaccines - Global Shares (2012, 2018 & 2022) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World European Poultry Vaccines Exhibit 50. Poultry Vaccines - European Historic, Current, and Forecast ( ) by Country for France, Germany, UK, the Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 51. Poultry Vaccines - European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, the Netherlands, Switzerland, Russia and Rest of Europe North American Poultry Vaccines T ABLE OF C ONTENTS Exhibit 52. Poultry Vaccines - North American Historic, Current, and Forecast ( ) by Country for United States and Canada in US$ Exhibit 53. Poultry Vaccines - North American Shares (2012, 2018 & 2022) by Country for United States and Canada Asia-Pacific Poultry Vaccines Exhibit 54. Poultry Vaccines - Asia-Pacific Historic, Current, and Forecast ( ) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific in US$ Exhibit 55. Poultry Vaccines - Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia- Pacific Latin American Poultry Vaccines Exhibit 56. Poultry Vaccines - Latin American Historic, Current, and Forecast ( ) by Country for Brazil, Mexico and Rest of Latin America in US$ Exhibit 57. Poultry Vaccines - Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America Middle East Poultry Vaccines Exhibit 58. Poultry Vaccines - Middle East Historic, Current, and Forecast ( ) by Country for Israel and Rest of Middle East in US$ Exhibit 59. Poultry Vaccines - Middle East Historic, Current, and Forecast Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies v

7 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT ( ) by Country for Israel and Rest of Middle East Rest of World Poultry Vaccines Exhibit 60. Poultry Vaccines - Rest of World Historic, Current, and Forecast ( ) by Country for South Africa and Other Countries in US$ Exhibit 61. Poultry Vaccines Rest of World Shares (2012, 2018 & 2022) by Country for South Africa and Other Countries Exhibit 63. Canine & Feline Vaccines - Global Shares (2012, 2018 & 2022) for Europe, North America, Asia- Pacific, Latin America, Middle East and Rest of World European Canine & Feline Vaccines Exhibit 64. Canine & Feline Vaccines - European Historic, Current, and Forecast ( ) for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 65. Canine & Feline Vaccines - European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe T ABLE OF C ONTENTS North American Canine & Feline Vaccines Exhibit 66. Canine & Feline Vaccines - North American Historic, Current, and Forecast ( ) by Country for United States and Canada in US$ Exhibit 67. Canine & Feline Vaccines - North American Shares (2012, 2018 & 2022) by Country for United States and Canada Asia-Pacific Canine & Feline Vaccines Canine & Feline Vaccines Exhibit 68. Canine & Feline Vaccines - Asia-Pacific Historic, Current, Global Canine & Feline and Forecast ( ) by Country Vaccines for Japan, Australia, China, India, Taiwan, Exhibit 62. Canine & Feline Vaccines - South Korea and Rest of Asia-Pacific in Global Historic, RI Current, Technologies, and US$ Forecast ( ) for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World in US$ Exhibit 69. Canine & Feline Vaccines - Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific Latin American Canine & Feline Vaccines Exhibit 70. Canine & Feline Vaccines - Latin American Historic, Current, and Forecast ( ) by Country for Brazil, Mexico and Rest of Latin America in US$ Exhibit 71. Canine & Feline Vaccines - Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America Middle East Canine & Feline Vaccines Exhibit 72. Canine & Feline Vaccines - Middle East Historic, Current, and Forecast ( )by Country Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies vi

8 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT for Israel and Rest of Middle East in US$ Exhibit 73. Canine & Feline Vaccines - Middle East Shares (2012, 2018 & 2022) by Country for Israel and Rest of Middle East Rest of World Canine & Feline Vaccines Exhibit 74. Canine & Feline Vaccines - Rest of World Historic, Current, and Forecast ( ) by Country for South Africa and Other Countries in US$ Exhibit 75. Canine & Feline Vaccines Rest of World Shares (2012, 2018 & 2022) by Country for South Africa and Other Countries T ABLE OF C ONTENTS Exhibit 82. Ovine & Caprine Vaccines Ovine & Caprine Vaccines Asia-Pacific Historic, Current, Global Ovine & Caprine Vaccines Exhibit 76. Ovine & Caprine Vaccines - Global Historic, Current, and Forecast ( ) by Geographic Region for Europe, North America, Asia- Pacific, Latin America, Middle East and Rest of World in US$ Exhibit 77. Ovine & Caprine Vaccines - Global Shares (2012, 2018 & 2022) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World European Ovine & Caprine Vaccines Exhibit 78. Ovine & Caprine Vaccines - European Historic, Current, and Forecast ( ) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 79. Ovine & Caprine Vaccines - European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe North American Ovine & Caprine Vaccines Exhibit 80. Ovine & Caprine Vaccines - North American Historic, Current, and Forecast ( ) by Country for United States and Canada in US$ Exhibit 81. Ovine & Caprine Vaccines - North American Shares (2012, 2018 & 2022) by Country for United States and Canada Asia-Pacific Ovine & Caprine Vaccines and Forecast ( ) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific in US$ Exhibit 83. Ovine & Caprine Vaccines - Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific Latin American Ovine & Caprine Vaccines Exhibit 84. Ovine & Caprine Vaccines - Latin American Historic, Current, and Forecast ( ) by Country for Brazil, Mexico and Rest of Latin America in US$ Exhibit 85. Ovine & Caprine Vaccines - Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America Middle East Ovine & Caprine Vaccines Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies vii

9 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Exhibit 86. Ovine & Caprine Vaccines - Middle East Historic, Current, and Forecast ( )by Country for Israel and Rest of Middle East in US$ Exhibit 87. Bovine & Caprine Vaccines - Middle East Shares (2012, 2018 & 2022) by Country for Israel and Rest of Middle East Rest of World Ovine & Caprine Vaccines Exhibit 88. Ovine & Caprine Vaccines - Rest of World Historic, Current, and Forecast ( ) by Country for South Africa and Other Countries in US$ T ABLE OF C ONTENTS Exhibit 89. Bovine & Caprine Vaccines Exhibit 95. Vaccines for Other Animal Rest of World Shares (2012, Species - North American Shares 2018 & 2022) by Country RI for Technologies, South (2012, 2018 & 2022) by Country for Africa and Other Countries United States and Canada Vaccines for Other Animal Species Global Vaccines for Other Animal Species Exhibit 90. Vaccines for Other Animal Species - Global Historic, Current, and Forecast ( ) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World in US$ Exhibit 91. Vaccines for Other Animal Species - Global Shares (2012, 2018 & 2022) by Geographic Region for Europe, North America, Asia-Pacific, Latin America, Middle East and Rest of World European Vaccines for Other Animal Species Exhibit 92. Vaccines for Other Animal Species - European Historic, Current, and Forecast ( ) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe in US$ Exhibit 93. Vaccines for Other Animal Species - European Shares (2012, 2018 & 2022) by Country for France, Germany, UK, The Netherlands, Switzerland, Russia and Rest of Europe North American Vaccines for Other Animal Species Exhibit 94. Vaccines for Other Animal Species - North American Historic, Current, and Forecast ( ) by Country for United States and Canada in US$ Asia-Pacific Vaccines for Other Animal Species Exhibit 96. Vaccines for Other Animal Species - Asia-Pacific Historic, Current, and Forecast ( ) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia- Pacific in US$ Exhibit 97. Vaccines for Other Animal Species - Asia-Pacific Shares (2012, 2018 & 2022) by Country for Japan, Australia, China, India, Taiwan, South Korea and Rest of Asia-Pacific Latin American Vaccines for Other Animal Species Exhibit 98. Vaccines for Other Animal Species - Latin American Historic, Current, and Forecast ( ) by Country for Brazil, Mexico and Rest of Latin America in US$ Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies viii

10 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Exhibit 99. Vaccines for Other Animal Species - Latin American Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America Middle East Vaccines for Other Animal Species Exhibit 100. Vaccines for Other Animal Species - Middle East Historic, Current, and Forecast ( ) by Country for Israel and Rest of Middle East in US$ Exhibit 101. Vaccines for Other Animal Species - Middle East Historic, Current, and Forecast ( ) by Country for Israel and Rest of Middle East T ABLE OF C ONTENTS Virbac S.A. (France) Rest of World Vaccines Zoetis (USA) for Other Animal Species Exhibit 102. Vaccines for Other Animal Species - Rest of World Historic, Current, and Forecast ( ) by Country for South Africa and Other Countries in US$ Exhibit 103. Vaccines for Other Animal Species Rest of World Shares (2012, 2018 & 2022) by Country for South Africa and Other Countries 3.10 Analysis by Type Exhibit 104. Veterinary Vaccines by Type - Global Historic, Current, and Forecast ( ) for Live Attenuated, Inactivated, Recombinant, and Other in US$ Exhibit 105. Veterinary Vaccines by Type - Global Shares (2012, 2018 & 2022) for Live Attenuated, Inactivated, Recombinant, and Other 3.11 Veterinary Vaccines Outlook 4. COMPETITOR DYNAMICS 4.1 Company Profiles - Major Global Manufacturers of Veterinary Vaccines Bayer HealthCare AG (Germany) Biogenesis-Bago (Argentina) Bioveta, a. s. (Czech Republic) Boehringer Ingelheim GmbH (Germany) CEVA Sante Animale (France) Elanco (USA) Indian Immunologicals Ltd. (IIL) (India) Merck Animal Health (USA) Merial (France) Narvac (Russia) Exhibit 106. Top Ten Global Animal Health Companies by Sales (2014 & 2013) in US$ Billion 4.2 Major Activities in Veterinary Vaccines Merck Animal Health Releases a New Fish Vaccine Valneva Obtains First Ever ing Approval in Europe for EB66 Cell Line Vaccine Boehringer Ingelheim Vetmedica Introduces ULTRA Fel-O-Vax Vétoquinol Acquires Animal Health Business of Bioniche Life Sciences Boehringer Ingelheim Introduces 3FLEX 50 Doses HSB Vaccine for Swine Lilly To Acquire Novartis Animal Health Elanco Inks an Agreement to Acquire Lohmann Animal Health Merck Animal Health Enters into Research Collaboration with Utrecht University for the Discovery of Porcine Epidemic Diarrhea Virus Vaccine Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies ix

11 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Newport Laboratories Launches TS6 Adjuvant Technology for Custom Made SIV Vaccines USDA Grants Conditional License to Zoetis for the First Vaccine against Georgia 08 Strain of Infectious Bronchitis Virus in Poultry Ceva Takes Over Sogeval Universiti Putra Malaysia Develops New Vaccine against Lung Diseases in Goats and Sheep Imaxio and VitamFero Enter into R&D Collaboration Boehringer Ingelheim Launches New XP Range of Vetera Vaccines T ABLE OF C ONTENTS Merck s Vista Vaccines Approved for Adaptive Immunity Utilization in Pregnant Cows and Calves Nursing Pregnant Cows Preparation of Vaccines More Methods of Vaccine Preparation 5. PRODUCT Cell Culture Products-Vaccines TECHNOLOGY/RESEARCH 5.2 Segmentation of Veterinary Vaccines 5.1 Introduction Animal Biologicals Immunity Vaccination Vaccines Veterinary Vaccinology: Hurdles and Progresses Vaccines Characteristics of Pathogens Target Species Wildlife as Reservoirs of Pathogen Immune Response of Hosts Economic Issues Regulations on Vaccines Immunology Cellular Immunology Cells and Components Involved Antibodies Antigens Cytokine Role of Cytokines Process of Immunity Antigen Recognition Co-Stimulation Memory Types of Immunity Innate Immunity Types of Vaccines Live Attenuated Inactivated Recombinant Other Types of Vaccines Toxoids Sub-unit Vaccines Conjugate Vaccines DNA Vaccines 5.3 Segmentation by Species Exhibit 107. Animal, Disease, Causative Agent, Name of Vaccine and Type of Vaccine Bovine Bovine Diseases Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies x

12 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT Exhibit 108. Bovine Diseases, Trade Name of the Vaccine and Company Producing the Vaccine Porcine Porcine Diseases Poultry Exhibit 109. List of Porcine Diseases, Trade Name of Vaccine and Company Producing the Vaccine Poultry Diseases Exhibit 110. List of Poultry Diseases, Trade Name of Vaccine and Company Producing the Vaccine T ABLE OF C ONTENTS Canine & Feline Agricultural Matters Canine & Feline Diseases Animal Health Policies/Strategies Exhibit 111. List of Canine Diseases, Ecological Concerns Trade Name of Vaccine and RI Technologies, Company Testing Veterinary Vaccines Producing the Vaccine Bioterrorism Exhibit 112. List of Feline Diseases, Trade Name of Vaccine and Company Exhibit 116. Bioterrorism- Causative Producing the Vaccine Agents, Species, Diagnosis and Vaccine Ovine & Caprine 5.4 Veterinary Vaccines - Research Briefs Ovine & Caprine Diseases Other Exhibit 113. List of Ovine Diseases, Trade Name of Vaccine and Company Producing the Vaccine Diseases in Other Species Exhibit 114. List of Equine Diseases, Trade Name of Vaccine and Company Producing the Vaccine Aquaculture Vaccines Animal Virology Foot-and-Mouth Disease Virus Pestiviruses Arteriviruses Coronaviruses Hendra and Nipha Virus Avian Influenza Bluetongue Virus Porcine Circoviruses Herpes Viruses African Swine Fever Virus Zoonoses Exhibit 115. Disease, Causative Agent, Species, Clinical Symptoms in Man, Clinical Symptoms in Animals and Method of Diagnosis To Overcome Serum Shortages, Vaccinate Cows Vaccine for Mutating Virus in Cows Animal Vaccines and Research Work on Malaria Vaccine Developed from Combination of Two Malaria Proteins Effective Approach to find E.coli Developed Equine Herpes Virus (EHV-1) Identified Immunotherapy: Potential Treatment for Canine Osteosarcoma A Vaccine to Protect Dairy Cows Animal Vaccine Study for HIV Vaccine Research IPN Virus in Atlantic Salmon Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies xi

13 RITMIR021 - VETERINARY VACCINES A MARKET INSIGHT REPORT T ABLE OF C ONTENTS Novel Diagnostic Tool to Detect Canine Parvovirus Information of How TB Evades the Immune System Could Help to Fight the Disease E. coli cattle Vaccination to Reduce Human Infection by 85% Increase in Resistance to Drug Treatment in Bovine Respiratory Disease Cases New Safe and Economical FMD Vaccine Progress in Finding New Vaccines for the Infectious Chicken Parasite Vaccine Candidate against the Lethal Pneumonia in Foals Recombinant Adenovirus as Vaccine against Rabies in Sheep Beginning of Foot-And-Mouth Disease Virus in Cattle, Identified Research on Vaccines to Help Catfish or Ailing Fish Research for the Development of the Elusive Bovine Mastitis Vaccine Vaccine for Poultry Disease Brings Short-Term Results but Creates Long-Term Difficulties OVC Research for a Better Avian Influenza Vaccine Encouraging Outcome for the Novel Vaccine against Horse Strangles Disease More. 6. CORPORATE DIRECTORY 7. PATENTS Table of Contents RITMIR021: VETERINARY VACCINES A Insight Report RI Technologies xii

14 1. SCOPE AND METHODOLOGY Scope of the Study Veterinary Vaccines report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bov ine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimates and projections for the total global Veterinary Vaccines market and also key regional markets that include Europe, North America, Asia Pacific Latin America, Middle East and Rest of World. Estimates and projections are illustrated graphically. Business profiles of 12 major companies are discussed in the report. The report serves as a guide to global Veterinary Vaccines industry, covering 360 companies that are engaged in the development and supply of Veterinary Vaccines. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Veterinary Vaccines report is an ideal research tool providing strategic business intelligence to the animal biologics corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in Gauging Competitive Intelligence Identifying Key Growth Areas and RI Technologies, Opportunities Understanding Geographic Relevance to Product Knowing Regional Sizes and Growth Opportunities and Restraints Keeping Tab on Emerging Technologies Equity Analysis Tapping New s Analytics and data presented in this report pertain to several parameters such as Global and Regional Sizes, Shares, Trends Product (Global and Regional) Sizes, Shares, Trends Technology Trends Corporate Intelligence Key Companies By Sales, Brands, Products Consumer Behavioral Patterns Other Strategic Business Affecting Data RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 1

15 Research Methodology RI Technologies publishes business intelligence reports by going through a cycle of diligent research and analysis activity. Research is done using both online and offline resources. The study outline of this report is sketched on the following lines global market analysis, regional market analysis, product segmentation, global and regional market analysis by product segment, market trends, M&A, R&D, competitive landscape, technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future. This report is uniquely researched and the methodology includes: Need and Scope of Study Product Definitions Segmental Analysis Regional Analysis Exclusive Data Analytics Corporate Intelligence Feedback Right from concept to final compilation of this report, both primary and secondary research methods are applied. We have provided exclusive feedback forms/pre release questionnaires for this report to use the information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Our compilation of easy to navigate PDF reports are essential value addition resources for leading and growing companies. RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 2

16 2. REPORT SYNOPSIS 2.1 Introduction Immunology Immunology is a broad branch of biomedical science that covers the study of all aspects of the immune system in all organisms. It deals with the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo. It has been proved that the infection occurs in the body only if the immune system is weak. Many infectious diseases affect the human body because of immune system disorders. So, Immunology plays a vital role in treating of harmful diseases and reducing the weakness of humans or animals. Immunology helps in diagnosis of the disease as a major criterion in identifying the abnormal changes that take place in vivo Immunity Immunity is a biological state wherein the body has the ability to withstand and fight against bodily disorders or the invasion of foreign bodies that may harm the body. The immune system may be both specific and nonspecific. Specific immunity is one that immunes the body against specific disorders that may from time to time affect the body. Specific immune components adopt themselves in such a way as to create pathogens that are equipped to fight against the specific medical condition. Nonspecific immunity is one that always keeps the body on alert against any unwarranted or unexpected disorder or foreign body invasion. Vaccine In general a vaccine can be defined as an immunity booster or an injection administered to offer resistance to certain types of specific diseases. The term vaccine comes from the Latin word "vacca" which means cow. This term is an extract from the word cowpox first used by Edward Jenner. 2.2 Segmentation of Veterinary Vaccines Exhibit 1. Segmentation of Global Veterinary Vaccines by Type and by Species By Type By Species Live Attenuated Bovine Inactivated Porcine Recombinant Poultry Other 1 Canine & Feline Ovine & Caprine Other 2 1. Includes Conjugate Vaccines, DNA Vaccines, Toxoids. 2. Includes Equines, Wild Animals, Fish and Other Pets. RIT, 2017 RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 3

17 2.3 Veterinary Vaccines Global Analysis Global for Veterinary Vaccines was estimated at US$ XX.XX billion in Global Veterinary Vaccines market is projected to reach US$ XX.XX billion by 2020 growing at a CAGR of XX.XX % during the analysis period ( ). Exhibit 2. Veterinary Vaccines Global Historic, Current, and Forecast ( ) in US$ Billion Year Value 2010 XX.XX 2011 XX.XX 2012 XX.XX 2013 XX.XX 2014 XX.XX CAGR% ( ) XX.XX 2015 XX.XX 2016 XX.XX 2017 XX.XX 2018 XX.XX 2019 XX.XX 2020 XX.XX 2021 XX.XX 2022 XX.XX CAGR% ( ) RIT Figures, 2017 US$ Billion XX.XX RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 4

18 3. MARKET DYNAMICS 3.1 Overview Trends Application of genomics and proteomics plays an important role in vaccinology and has resulted in developing new vaccines and also improving the efficiency of present vaccines. Subunit vaccines, recombinant vaccines, DNA vaccines and vectored vaccines are rapidly gaining scientific and public acceptance as the new generation of vaccines and are considered as alternatives to current conventional vaccines. Almost 2000 of the licensed vaccines in the US are killed or live attenuated bacteria or viruses. Development in molecular biology, immunology and genetics has enhanced the production of safer and more effective vaccines. It is also pivotal to formulate and deliver these vaccines appropriately to maximize its potential in pathogenesis and vaccinology. Research and Selective Breeding Immunological research in animal species and means of stimulation of immunity should be intensified greatly. This is made easier with the RI access Technologies, to genome sequences of major species such as cattle, dogs, pigs etc. Research on adjuvants which are cable of stimulating innate immunity is also of major importance. The methods of vaccine administration are an important aspect in veterinary vaccinology, especially in the case of vaccines for wild and domestic animals. These animals are not only hosts to identified diseases, but also for potential diseases that have not been identified yet. Certain vaccines are meant only for the preservation of endangered species. Guidelines for Small Animal Vaccines In January, 2008 the (World Small Animal Veterinary Association (WSAVA)has laid down some guidelines whose main principal is to ensure that each and every animal in the world is vaccinated so that the frequency of vaccination of human beings is reduced. The organization strives at the bare minimum to ensure the vaccination of dogs and cats. The reason for giving top priority to dogs and cats is that these are domestic animals that come into touch with human beings most often. The vaccination of these animals would prevent the spread of infectious diseases and would optimize the immunity against such diseases. The basic vaccinations recommended by WSAVA are canine adenovirus (CAV), canine parvovirus (CPV), canine distemper virus (CDV), feline calicivirus (FCV), feline herpesvirus (FHV), and feline parvovirus (FPV). Apart from these there are other medications that are suggested by the organization based on the local requirements. WSAVA also recommends for an annual checkup of the animals. RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 5

19 3.2 Global Veterinary Vaccines Analysis The global market for Veterinary Vaccines is projected to reach about US$XX.XX billion by 2022, from an estimated US$ XX.XX billion in 2014, growing at a compounded annual growth rate (CAGR) of XX.XX % during Europe is estimated as the largest market for veterinary vaccines with a share of XX.XX %, valued at US$ XX.XX billion in The market is projected to cross US$ XX.XX billion by Asia Pacific is the fastest growing market, with a CAGR of XX.XX % during ( ). North America is projected to be the second largest market valued at US$ XX.XX billion by Latin America closely follows Asia pacific in the global veterinary vaccines market with a (CAGR) of XX.XX % during Exhibit 4. Veterinary Vaccines Global Historic, Current, and Forecast ( ) by Geographic Region for Europe, North America, Asia Pacific, Latin America, Middle East and Rest of World in US$ Year/Region Europe North America Asia Pacific Latin America Middle East Rest of World 2010 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2011 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2012 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2013 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2014 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% (2010 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2014) 2015 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2016 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2017 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2019 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2021 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2022 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% ( ) XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX RIT Figures, 2017 US$ Total Europe North America Asia Pacific Latin America Middle East Rest of World RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 6

20 Exhibit 5. Veterinary Vaccines Global Shares (2012, 2018 & 2022) by Geographic Region for Europe, North America, Asia Pacific, Latin America, Middle East and Rest of World Year/Region Europe North America Asia Pacific Latin America Middle East Rest of World 2012 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX 2022 XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX XX.XX RIT Figures, 2017 Total RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 7

21 3.10 Analysis by Type Global for Live Attenuated, Veterinary Vaccines is the largest type with an estimated value of US$ XX.XX billion in 2014 and is projected to reach US$ XX.XX billion by 2022 growing at a CAGR of XX.XX %. Recombinant Vaccine is the fastest growing type with a CAGR of XX.XX % during the period Exhibit 104. Veterinary Vaccines by Type Global Historic, Current, and Forecast ( ) for Live Attenuated, Inactivated, Recombinant, and Other in US$ Year/Type Live Attenuated Inactivated Recombinant Other Total 2010 XX.XX XX.XX XX.XX XX.XX XX.XX 2011 XX.XX XX.XX XX.XX XX.XX XX.XX 2012 XX.XX XX.XX XX.XX XX.XX XX.XX 2013 XX.XX XX.XX XX.XX XX.XX XX.XX 2014 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% ( ) XX.XX XX.XX XX.XX XX.XX XX.XX 2015 XX.XX XX.XX XX.XX XX.XX XX.XX 2016 XX.XX XX.XX XX.XX XX.XX XX.XX 2017 XX.XX XX.XX XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX XX.XX XX.XX 2019 XX.XX XX.XX XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX XX.XX XX.XX 2021 XX.XX XX.XX XX.XX XX.XX XX.XX 2022 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% ( ) XX.XX XX.XX XX.XX XX.XX XX.XX RIT Figures, 2017 US$ Live Attenuated Inactivated Recombinant Other RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 8

22 3.11 Veterinary Vaccines Outlook The potential of vaccines to improve efficiency of growth, immunity towards diseases, and to lower the rate of mortality became a critical factor in prevention of diseases. The global veterinary vaccines market is rapidly growing at a CAGR of 6.58% and is projected to reach about US$9.5 billion by 2020, from an estimated US$5.6 billion in Europe is estimated as the largest market for veterinary vaccines with a share of 33.54%, valued at US$ 1.8 billion in The market is projected to cross US$ 3 billion by Asia Pacific is the fastest growing market, with a CAGR of 7.67% during ( ). North America is projected to be the second largest market valued at US$2.8 billion by Latin America closely follows Asia pacific in the global veterinary vaccines market with a CAGR of 7.20% during Europe is the leading market, with almost 34% of global market share in 2012, and is closely followed by North America. Europe is projected to manage the leading position throughout the analysis period with its share dropping to 31.86% by Due to high susceptibility to diseases and heavy demand, Asia Pacific is the fastest growing (7.67% during ) market for Veterinary Vaccines. 4. Competitor Dynamics 4.1 Company Profiles - Major Global Manufacturers of Veterinary Vaccines Bayer HealthCare AG (Germany) Biogenesis-Bago (Argentina) Bioveta, a. s. (Czech Republic) Boehringer Ingelheim GmbH (Germany) CEVA Sante Animale (France) Elanco (USA) More Major Activities in Veterinary Vaccines Merial Introduces Combination Vaccine for Core Canine Diseases and Comprehensive Leptospirosis Protection USDA Granted Production Platform Vaccine Licensure to Harrisvaccines Merck Animal Health Receives European Commission Approval for First Intradermal Vaccine against Porcine Circovirus Type 2 Merck Animal Health Releases a New Fish Vaccine Valneva Obtains First Ever ing Approval in Europe for EB66 Cell Line Vaccine Boehringer Ingelheim Vetmedica Introduces ULTRA Fel-O-Vax Vétoquinol Acquires Animal Health Business of Bioniche Life Sciences Boehringer Ingelheim Introduces 3FLEX 50 Doses HSB Vaccine for Swine Lilly To Acquire Novartis Animal Health Elanco Inks an Agreement to Acquire Lohmann Animal Health Merck Animal Health Enters into Research Collaboration with Utrecht University for the Discovery of Porcine Epidemic Diarrhea Virus Vaccine Newport Laboratories Launches TS6 Adjuvant Technology for Custom Made SIV Vaccines USDA Grants Conditional License to Zoetis for the First Vaccine against Georgia 08 Strain of Infectious Bronchitis Virus in Poultry RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 9

23 Ceva Takes Over Sogeval Universiti Putra Malaysia Develops New Vaccine against Lung Diseases in Goats and Sheep Imaxio and VitamFero Enter into R&D Collaboration Boehringer Ingelheim Launches New XP Range of Vetera Vaccines Merck s Vista Vaccines Approved for Utilization in Pregnant Cows and Calves Nursing Pregnant Cows More 5. PRODUCT TECHNOLOGY/RESEARCH Exhibit 107. Animal, Disease, Causative Agent, Name of Vaccine and Type of Vaccine Animal Disease Causative Agent Name of Vaccine Type of Vaccine Cattle and Haemorrhagic P. multocida Type Haemorrhagic Septicaemia Killed Vaccine Buffalo Septicaemia B:2 Double Adjuvant Vaccine Cattle and Buffalo Cattle and Buffalo Haemorrhagic Septicaemia P. multocida Type B:2 Salmonellosis S. dublin and S. typhimurium Ducks Pasteurellosis P. multocida and R. anatipestifer Haemorrhagic Septicaemia Alum Precipitated Vaccine Salmonella Double Adjuvant Vaccine Duck Pasteurellosis Alum Precipitate Vaccine Chicken Fowl Cholera P. multocida Type A Fowl Cholera Alum Precipitated Vaccine Chicken Infectious coryza H. paragallinarum Alum Precipitate Inactivated RI Types Technologies, A and C Infectious Coryza Vaccine Chicken Chicken Newcastle Disease or Pseudo fowl Pest Newcastle Disease Newcastle Disease Virus Newcastle Disease Virus Newcastle Disease Vaccine ( Modified Live Virus Vaccine, Strain A) Newcastle Disease Vaccine ( Modified Live Virus Vaccine, Strain M) Chicken Fowl pox Avipoxvirus. Fowl Pox Vaccine (Live Virus Vaccine Beaudette Strain) Broilers and Layers Chicks Ducks Sheep and Goats RIT, 2017 Infectious Bronchitis Infectious Bursal Disease Coronavirus Infectious Bursal Disease Virus Duck Virus Duck Herpes Virus 1 Enteritis (DVE) or Duck Plague Pasteurellosis P. multocida and P. haemolytica Infectious Bronchitis (Uremic) Vaccine, (Modified Live Virus, Malaysian strain) Infectious Bursal Disease Vaccine (Modified Live Virus, Malaysian strain) Duck Virus Enteritis Vaccine (Modified Live Virus, Malaysian strain) Sheep / Goat Pasteurellosis Alum Precipitate Vaccine Killed Vaccine Killed Oil Adjuvant Vaccine Killed Vaccine Alum Precipitated Vaccine Alum Precipitated Inactivated Vaccine Freeze Dried Live Virus Vaccine Freeze Dried Vaccine Live Virus Vaccine Lyopholised Live Vaccine Live Virus Vaccine Live Lypholised Intermediate IBD Vaccine Lyopholised Live Attenuated Alum Precipitated Killed Vaccine Click Here: Abstract /Features/Highlights/Chapters/Companies Discussed/Why Buy?/Questions/Buy Report/Related Reports RITMIR021: Veterinary Vaccines A Insight Report RI Technologies - Sample Page - 10

24 About RI Technologies RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. Research As Good as the Methodology is! Gauging Competitive Intelligence Identifying Key Growth Areas and Opportunities Understanding Geographic Relevance to Product Knowing Regional Sizes and Growth Opportunities and Restraints Keeping Tab on Emerging Technologies Equity Analysis Tapping New s COPYRIGHT The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company. DISCLAIMER RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data. RITMIR021: Veterinary Vaccines A Insight Report RI Technologies -

25 Consultative Approach! Collaborative Analysis! Potential Client Speak "I need to focus on strategic opportunities" - Sales & ing Professional "Am I spending on the right content?" - Resource Librarian "I require easy methods to search and share reports and insights" - Research Professional "I need market research that helps us make strategic decisions, keep pace and lets us keep control too" - Company Head All your questions will find answers in our reports. You may order this report here. If you have any specific data requests, you may order a custom research order with us too. Thank You. We greatly appreciate your time and effort. Contact Us: Research Impact Technologies /B/2, New Nallakunta (+91) Hyderabad (+91) Telangana, India contactus@researchimpact.com RITMIR021: Veterinary Vaccines A Insight Report RI Technologies -